Sonova (OTCMKTS:SONVY – Get Free Report) was upgraded by stock analysts at The Goldman Sachs Group to a “strong sell” rating in a report released on Tuesday, Zacks.com reports.
Separately, UBS Group raised shares of Sonova to a “hold” rating in a report on Tuesday, August 13th.
Check Out Our Latest Stock Analysis on Sonova
Sonova Stock Performance
About Sonova
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Read More
- Five stocks we like better than Sonova
- ESG Stocks, What Investors Should Know
- Bet on These 3 High-Yield Stocks as Natural Gas Demand Grows
- What Does a Stock Split Mean?
- Gold Prices Hit Record Highs: Is It Time to Buy or Take Profits?
- What is the Nasdaq? Complete Overview with History
- Value Stocks Gaining Momentum – Will They Beat Growth Stocks?
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.